期刊文献+

BCG初免的异源加强疫苗研究进展

Research progress in heterologous boost vaccines for Bacillus Calmette-Guerin prime immunization
原文传递
导出
摘要 结核病是由结核杆菌引起的一种流传广、危害大的传染病。目前,结核病在全球的流行越来越严重,是导致成年人死亡的主要传染病之一,也是艾滋病感染群体的首位致死原因。为了控制结核病蔓延,目前迫切需要一种特异、高效的新型抗结核病疫苗及其免疫策略。异源初免-加强免疫策略为预防结核病带来了新希望。此文综述了BCG初免的异源加强疫苗及其免疫策略的研究进展。 Tuberculosis(TB) is a prevalent and harmful infectious disease caused by Mycobacterium tuberculosis. Nowadays, TB is more and more seriously prevalent worldwide, and remains one of the main infectious diseases for adult death as well as the leading cause of death among AIDS patients. There is an urgent need to develop a new specific and efficient vaccine against TB and immunization regimen for TB control. The heterologous prime-boost immunization strategy brings a promise for TB prophylaxis. This review will discuss research advances in heterologous boost vaccines for Bacillus Calmette-Guerin prime immunization and its immunization regimen.
出处 《国际生物制品学杂志》 CAS 2009年第5期246-249,共4页 International Journal of Biologicals
关键词 结核 分枝杆菌 免疫接种 加强 异源疫苗 Tuberculosis Mycobacterium bovis Immunization, secondary Heterologous vaccines
  • 相关文献

参考文献33

  • 1WHO. Global tuberculosis control: surveillance, planning, financing:WHO report 2007 [ R ]. Geneva :WHO, 2007.
  • 2Mustafa Abu S, Al-Attiyah R. Tuberculosis :looking beyond BCG vaccines [J]. J Postgrad Med, 2003, 49(2) :134-140.
  • 3Xing Z, Santosuosso M, McCormick S, et al. Recent advances in the development of adenovirus-and poxvirus-vectored tuberculosis vaccines [J]. Curr Gene Ther, 2005, 5(5) :485-492.
  • 4Skeiky YA, Sadoff JC. Advances in tuberculosis vaccine strategies [J]. Nat Rev Microbiol, 2006, 4(6) :469-476.
  • 5McShane H, Hill A. Prime-boost immunisation strategies for tuberculosis [ J]. Microbes Infect, 2005, 7 (5/6) :962- 967.
  • 6Estcourt MJ, Ramsay AJ, Brooks A, et al. Prime-boost immunization generates a high frequency, high-avidity CD8 ( + ) cytotoxic T lymphocyte population [ J ]. Int Immunol, 2002, 14 (1) :31-37.
  • 7Yewdell JW, Bennink JR. Immunodominance in major histocompatibitity complex class Ⅰ-restricted T lymphocyte responses [ J ].Annu Rev Immunol, 1999, 17:51-88.
  • 8Ghosh SS, Gopinath P, Ramesh A. Adenoviral vectors : a promising tool for gene therapy [ J ]. Appl Biochem Biotechnol, 2006, 133 ( 1 ) :9-29.
  • 9Xing Z, Braciak T, Ohkawara Y, et al. Gene transfer for cytokine functional studies in the lung: the multifunctional role of GM-CSF in pulmonary inflammation [ J]. J Leukoc Biol, 1996, 59(4) :481-488.
  • 10Tatsis N, Ertl HC. Adenoviruses as vaccine vectors [ J]. Mol Ther, 2004, 10(4) :616-629.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部